Biotage: Year-end report 2006.STOCKHOLM, Sweden -- Biotage (STO STO Store (calculator function) STO Société de Transport de l'Outaouais (French) STO Strategic Technology Office (DARPA) STO Security Through Obscurity STO Service to Others :BIOTA) achieves profit for the full year and continues its positive profit development in the fourth quarter. * For the full year 2006 Biotage reports a 2.8 MSEK MSEK Meyer, Suozzi, English & Klein (New York law firm) MSEK Million Swedish Kroner profit (-39.9 MSEK last year). The positive development of the operating result and the result after tax continued during the fourth quarter. The cash flow for the operating activities was very strong in the fourth quarter. * Net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight increased by 21% to 519.5 MSEK (430.4) in the full year 2006. At constant exchange rates and pro-forma(1) the full year increase was approx. 9%. In the fourth quarter net sales decreased by 1% and amounted to 136.6 MSEK (138.4). At constant exchange rates and pro-forma(1) the increase was a 7%. * The operating result for the full year improved by 69.4 MSEK and amounted to 6.5 MSEK (-62.9). In the fourth quarter the operating result improved to 9.4 MSEK (-4.7). * The result after tax amounted to 2.8 MSEK (-39.9) for the full year and to 11.0 MSEK (0.4) in the fourth quarter. * Earnings per share amounted to 0.03 SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. (-0.57) for the full year and to 0.12 SEK (0.01) in the fourth quarter. * The cash flow from operating activities has improved considerably and amounted to 39.9 MSEK (-21.7) for the full year and to 28.0 MSEK (10.2) in the fourth quarter. The positive cash flow development is among other things attributable to the positive results development and to improvements of the working capital. * The Biosystems business area developed very well, in the fourth quarter as well as in the full year. Sales have increased and the business area has had good profitability in 2006. * Biotage is running five major product development projects. In the first six months of 2007 we will launch a new series of consumables and re-launch the company's evaporation evaporation, change of a liquid into vapor at any temperature below its boiling point. For example, water, when placed in a shallow open container exposed to air, gradually disappears, evaporating at a rate that depends on the amount of surface exposed, the humidity system. (1) Note: Pro-forma refers to an adjustment for the distribution of Corbett's products in the Biosystems business area (divested in 2005), and for the Argonaut business in the Discovery Chemistry business area (acquired on June 3, 2005). The pro-forma figures have not been subject to review by the company's accountant. About Biotage Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term Long-term Three or more years. In the context of accounting, more than 1 year. long-term 1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term. view of the market. The company offers solutions, knowledge and experience in the areas of genetic analysis and medicinal chemistry Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs. . In 2005 business and products from the company Argonaut were acquired, further strengthening the product range in medicinal chemistry. The customers include the world's top 30 pharma companies, the world's top 20 biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the U.S., Japan, UK, Germany and several other European countries. Biotage has 332 employees and had sales of 520 MSEK in 2006. Biotage is listed on the Stockholm stock exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. . Website: www.biotage.com This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion